Autobio Diagnostics Co., Ltd.

SHSE:603658 Rapport sur les actions

Capitalisation boursière : CN¥23.3b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Autobio Diagnostics Résultats passés

Passé contrôle des critères 4/6

Autobio Diagnostics has been growing earnings at an average annual rate of 14.9%, while the Medical Equipment industry saw earnings growing at 5.8% annually. Revenues have been growing at an average rate of 15.2% per year. Autobio Diagnostics's return on equity is 14.7%, and it has net margins of 28.9%.

Informations clés

14.9%

Taux de croissance des bénéfices

13.4%

Taux de croissance du BPA

Medical Equipment Croissance de l'industrie16.0%
Taux de croissance des recettes15.2%
Rendement des fonds propres14.7%
Marge nette28.9%
Prochaine mise à jour des résultats21 Aug 2024

Mises à jour récentes des performances passées

Recent updates

Autobio Diagnostics Co., Ltd. (SHSE:603658) Shares Could Be 35% Above Their Intrinsic Value Estimate

Aug 09
Autobio Diagnostics Co., Ltd. (SHSE:603658) Shares Could Be 35% Above Their Intrinsic Value Estimate

Improved Earnings Required Before Autobio Diagnostics Co., Ltd. (SHSE:603658) Shares Find Their Feet

Jul 18
Improved Earnings Required Before Autobio Diagnostics Co., Ltd. (SHSE:603658) Shares Find Their Feet

Does Autobio Diagnostics (SHSE:603658) Have A Healthy Balance Sheet?

May 21
Does Autobio Diagnostics (SHSE:603658) Have A Healthy Balance Sheet?

Autobio Diagnostics Co., Ltd.'s (SHSE:603658) 27% Price Boost Is Out Of Tune With Earnings

Feb 27
Autobio Diagnostics Co., Ltd.'s (SHSE:603658) 27% Price Boost Is Out Of Tune With Earnings

Ventilation des recettes et des dépenses

Comment Autobio Diagnostics gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.


Historique des gains et des recettes

SHSE:603658 Recettes, dépenses et bénéfices (CNY Millions )
DateRecettesLes revenusDépenses G+ADépenses de R&D
31 Mar 244,4961,300949655
31 Dec 234,4441,217941656
30 Sep 234,4031,169925633
30 Jun 234,4791,180915627
31 Mar 234,4471,169864600
31 Dec 224,4421,167874568
30 Sep 224,3521,156879540
30 Jun 224,1591,095827508
31 Mar 223,9801,042810498
31 Dec 213,766974772481
30 Sep 213,626950733445
30 Jun 213,450887713420
31 Mar 213,245826665376
31 Dec 202,978748616343
30 Sep 202,833751587322
30 Jun 202,706728574321
31 Mar 202,682746560318
31 Dec 192,679774564312
30 Sep 192,463689524294
30 Jun 192,261636467261
31 Mar 192,062588445229
31 Dec 181,930563404213
30 Sep 181,777534383188
30 Jun 181,666502292234
31 Mar 181,574475307191
31 Dec 171,400447301143
30 Sep 171,27141929399
30 Jun 171,1293933550
31 Mar 171,0303633240
31 Dec 169803503010
30 Sep 168983352600
30 Jun 168373172250
31 Mar 167522782200
31 Dec 157162782030
31 Dec 145632081730
31 Dec 134091241500

Des revenus de qualité: 603658 has high quality earnings.

Augmentation de la marge bénéficiaire: 603658's current net profit margins (28.9%) are higher than last year (26.3%).


Analyse des flux de trésorerie disponibles par rapport aux bénéfices


Analyse de la croissance passée des bénéfices

Tendance des revenus: 603658's earnings have grown by 14.9% per year over the past 5 years.

Accélération de la croissance: 603658's earnings growth over the past year (11.1%) is below its 5-year average (14.9% per year).

Bénéfices par rapport au secteur d'activité: 603658 earnings growth over the past year (11.1%) exceeded the Medical Equipment industry 1.7%.


Rendement des fonds propres

ROE élevé: 603658's Return on Equity (14.7%) is considered low.


Rendement des actifs


Rendement des capitaux employés


Découvrir des entreprises performantes dans le passé